PharmaCyte Biotech Inc (PMCB) — Net Asset Quality Index
PharmaCyte Biotech Inc (PMCB) has a Net Asset Quality Index of 74.8% as of April 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $46.75 Million minus total liabilities of $11.77 Million yields net assets of $34.98 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read PMCB liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
PharmaCyte Biotech Inc Net Asset Quality Index Over Time (2004–2026)
This chart shows how PharmaCyte Biotech Inc's Net Asset Quality Index has evolved across 23 annual periods from 2004 to 2026. As of April 2026, the index stands at 74.8%, representing net assets of $34.98 Million against total assets of $46.75 Million USD. For live market cap and overall valuation, see PharmaCyte Biotech Inc stock valuation.
Annual Net Asset Quality Index for PharmaCyte Biotech Inc (2004–2026)
The table below presents the year-by-year Net Asset Quality Index for PharmaCyte Biotech Inc from 2004 to 2026, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check PharmaCyte Biotech Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 74.8% | $34.98 Million | $46.75 Million | $11.77 Million | ▼ -19.2 pp |
| 2025 | 94.1% | $51.89 Million | $55.17 Million | $3.28 Million | ▲ +28.1 pp |
| 2024 | 66.0% | $39.51 Million | $59.90 Million | $20.39 Million | ▼ -33.2 pp |
| 2023 | 99.2% | $72.69 Million | $73.28 Million | $586.58K | ▼ 0.0 pp |
| 2022 | 99.2% | $89.92 Million | $90.62 Million | $704.37K | ▲ +9.0 pp |
| 2021 | 90.2% | $6.68 Million | $7.40 Million | $724.78K | ▲ +7.7 pp |
| 2020 | 82.5% | $5.09 Million | $6.17 Million | $1.08 Million | ▼ -4.6 pp |
| 2019 | 87.2% | $5.04 Million | $5.78 Million | $742.85K | ▼ -2.8 pp |
| 2018 | 90.0% | $5.77 Million | $6.41 Million | $644.17K | ▼ -3.4 pp |
| 2017 | 93.3% | $8.09 Million | $8.67 Million | $580.25K | ▲ +2.2 pp |
| 2016 | 91.1% | $6.52 Million | $7.16 Million | $637.64K | ▲ +16.4 pp |
| 2015 | 74.7% | $5.94 Million | $7.95 Million | $2.01 Million | ▼ -21.3 pp |
| 2014 | 96.0% | $8.94 Million | $9.32 Million | $373.67K | ▲ +128.0 pp |
| 2013 | -32.0% | $-921.46K | $2.88 Million | $3.80 Million | ▲ +49.4 pp |
| 2012 | -81.4% | $-1.70 Million | $2.09 Million | $3.79 Million | ▲ +138.6 pp |
| 2011 | -220.1% | $-2.73 Million | $1.24 Million | $3.97 Million | ▼ -57.8 pp |
| 2010 | -162.3% | $-1.95 Million | $1.20 Million | $3.15 Million | ▼ -214.0 pp |
| 2009 | 51.7% | $3.12 Million | $6.04 Million | $2.92 Million | ▼ -45.9 pp |
| 2008 | 97.6% | $7.44 Million | $7.62 Million | $180.56K | ▲ +0.3 pp |
| 2007 | 97.3% | $4.29 Million | $4.41 Million | $118.81K | ▲ +11.4 pp |
| 2006 | 85.9% | $4.41 Million | $5.14 Million | $723.89K | ▲ +470.9 pp |
| 2005 | -385.0% | $-1.30 Million | $336.36K | $1.63 Million | ▼ -297.7 pp |
| 2004 | -87.3% | $-153.43K | $175.71K | $329.13K | — |